Diffuse Midline Glioma H3 K27M-Mutant Latest Advances

Find the Latest Research About Diffuse Midline Glioma H3 K27M-Mutant

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 727 publications

The DIPG/DMG National Tumor Board: The power of advocacy.

The DIPG/DMG National Tumor Board: The power of advocacy.

Journal: Neuro-oncology pediatrics
Published: August 06, 2026

Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids.

Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids.

Journal: Journal of medicinal chemistry
Published: July 08, 2026

Tunable Nanoparticle Thin-Film Reveals Distance Dependence of Auger-Mediated Radiation Enhancement in Diffuse Midline Glioma.

Tunable Nanoparticle Thin-Film Reveals Distance Dependence of Auger-Mediated Radiation Enhancement in Diffuse Midline Glioma.

Journal: ACS nano
Published: July 03, 2026

Focused ultrasound in pediatric neuro-oncology: Current applications and future directions.

Focused ultrasound in pediatric neuro-oncology: Current applications and future directions.

Journal: Neuro-oncology advances
Published: June 12, 2026

A RaPID Macrocyclic Peptide Inhibitor of ROR1/2 Strongly Reduces Proliferation of Diffuse Intrinsic Pontine Glioma Cells.

A RaPID Macrocyclic Peptide Inhibitor of ROR1/2 Strongly Reduces Proliferation of Diffuse Intrinsic Pontine Glioma Cells.

Journal: ACS chemical biology
Published: June 09, 2026

Beyond Acute EGFR Blockade: Biological Basis and Clinical Evidence for Long-Term Nimotuzumab Therapy.

Beyond Acute EGFR Blockade: Biological Basis and Clinical Evidence for Long-Term Nimotuzumab Therapy.

Journal: Biomedicines
Published: May 31, 2026

Integrated Proteomic and Metabolomic Analyses of Cerebrospinal Fluid from Pediatric Patients with Diffuse Intrinsic Pontine Glioma.

Integrated Proteomic and Metabolomic Analyses of Cerebrospinal Fluid from Pediatric Patients with Diffuse Intrinsic Pontine Glioma.

Journal: International journal of molecular sciences
Published: May 17, 2026

A new hope: Clinical advances in targeted therapies for pediatric diffuse midline glioma.

A new hope: Clinical advances in targeted therapies for pediatric diffuse midline glioma.

Journal: Neuro-oncology advances
Published: April 30, 2026

CAR T-cell therapy in pediatric brain tumors: a narrative review with comparative analysis of clinical trial eligibility criteria.

CAR T-cell therapy in pediatric brain tumors: a narrative review with comparative analysis of clinical trial eligibility criteria.

Journal: Frontiers in oncology
Published: April 30, 2026

Modeling diffuse midline glioma through triple-electrode in utero electroporation of the developing mouse pons.

Modeling diffuse midline glioma through triple-electrode in utero electroporation of the developing mouse pons.

Journal: PloS one
Published: April 17, 2026

Efficacy of chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic pontine glioma: a study based on single-center and SEER data.

Efficacy of chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic pontine glioma: a study based on single-center and SEER data.

Journal: Journal of neuro-oncology
Published: April 16, 2026

Reirradiation for diffuse intrinsic pontine glioma in an upper middle-income country: does full dose improve outcomes?

Reirradiation for diffuse intrinsic pontine glioma in an upper middle-income country: does full dose improve outcomes?

Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
Published: April 10, 2026
Showing 1-12 of 727

Last Updated: 09/26/2026